Does INOTUZUMAB OZOGAMICIN Cause Bone marrow failure? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Bone marrow failure have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 1.0% of all adverse event reports for INOTUZUMAB OZOGAMICIN.
23
Reports of Bone marrow failure with INOTUZUMAB OZOGAMICIN
1.0%
of all INOTUZUMAB OZOGAMICIN reports
10
Deaths
7
Hospitalizations
How Dangerous Is Bone marrow failure From INOTUZUMAB OZOGAMICIN?
Of the 23 reports, 10 (43.5%) resulted in death, 7 (30.4%) required hospitalization, and 1 (4.3%) were considered life-threatening.
Is Bone marrow failure Listed in the Official Label?
Yes, Bone marrow failure is listed as a known adverse reaction in the official FDA drug label for INOTUZUMAB OZOGAMICIN.
What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?
Death (253)
Febrile neutropenia (230)
Venoocclusive liver disease (229)
Neoplasm progression (158)
Pyrexia (151)
Off label use (146)
Sepsis (119)
Venoocclusive disease (109)
Thrombocytopenia (108)
Platelet count decreased (107)
What Other Drugs Cause Bone marrow failure?
CYCLOPHOSPHAMIDE (1,834)
METHOTREXATE (1,401)
ETOPOSIDE (1,081)
RITUXIMAB (1,060)
CYTARABINE (1,052)
VINCRISTINE (1,001)
DOXORUBICIN (1,000)
PALBOCICLIB (951)
CARBOPLATIN (855)
BEVACIZUMAB (835)
Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Bone marrow failure Risk?
INOTUZUMAB OZOGAMICIN vs INSULIN
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTUZUMAB OZOGAMICIN vs INSULIN BEEF
INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC